Test Price
36,000 AED✅ Home Collection Available
Homologous Recombination Deficiency (HRD) Genomic Signature Testing in UAE | 36000 AED | 2026 DHA Guidelines
تحليل التوقيع الجينومي لنقص التأشيب المتماثل (HRD) في الإمارات | 36000 درهم | معتمد من هيئة الصحة بدبي
الفحص الجينومي لنقص التأشيب المتماثل (HRD) ضروري لتقييم قابلية الإصابة بالسرطان وتوجيه العلاج الموجه، وفق أعلى معايير الجودة الإماراتية.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed physicians.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
Homologous Recombination Deficiency (HRD) Genomic Signature Testing is a next‑generation sequencing (NGS) assay that evaluates tumor DNA for defects in homologous recombination repair pathways, guiding targeted therapy selection — particularly PARP inhibitors — for breast, ovarian, pancreatic, and prostate cancers. يتيح هذا الاختبار الكشف عن الطفرات الجينية المؤثرة على إصلاح الحمض النووي، مما يساعد الأطباء على اتخاذ قرارات علاجية دقيقة.
| Feature | Our Test (HRD Genomic Signature) | Closest Alternative (BRCA1/2 Alone) |
|---|---|---|
| Precision | Genome‑wide HRD Score + BRCA status | Mutation‑specific, misses epigenetic silencing |
| Methodology | NGS (Next‑Generation Sequencing) | Sanger sequencing or limited panel |
| Speed & Actionability | 3‑4 weeks TAT; direct PARP inhibitor eligibility report | May require reflex testing, longer clinical decision time |
Physician Insight & Safety Protocol
A Note from Dr. PRABHAKAR REDDY (DHA: 61713011): “An HRD positive result is a critical biomarker that can significantly expand treatment options, yet it must always be interpreted within the full clinical context. No genomic test replaces thorough oncological evaluation. Our team is here to guide you through every result with empathy and clinical precision.”
Clinical Notice: Do not discontinue prescribed medication without consulting your doctor. This test does not replace a comprehensive cancer management plan.
Exclusion Criteria & Emergency Red Flags
- Inability to provide adequate tumor tissue (biopsy or surgical specimen) or peripheral blood.
- Known allergy to local anesthetics if a tissue biopsy is required.
- Active anticoagulant therapy that cannot be safely interrupted for sample collection (requires physician clearance).
- Acute febrile illness or systemic infection at time of collection.
- ER Red Flags: If you experience severe pain, excessive bleeding, or signs of infection (redness, swelling, fever) after a biopsy, seek immediate medical attention.
Pre‑Test Requirement: A doctor's prescription is mandatory. Exception: prescription is not applicable for individuals planning surgery, pregnancy cases, or those traveling abroad (as per UAE CDS Law 2026). No dietary or supplement restrictions are required; however, please follow all home collection instructions provided by our logistics team.
Sample Types: Tumor tissue (FFPE or fresh) + Peripheral blood (EDTA tube). TAT: 3‑4 weeks.
Patient FAQ & Clinical Guidance
What is HRD testing, and how can it help me?
HRD testing identifies DNA repair defects in tumors, guiding targeted therapy choices for cancer patients.
This advanced genomic analysis measures genomic instability scores, including loss of heterozygosity, telomeric allelic imbalance, and large‑scale state transitions, which together predict sensitivity to PARP inhibitors. Results enable personalization of treatment for ovarian, breast, pancreatic, and prostate malignancies, often revealing therapeutic options that might otherwise be overlooked.
ما هي أهمية تحليل HRD لمرضى السرطان في الإمارات؟
فحص HRD يكشف عيوب ترميم الحمض النووي في الأورام، ويوجه خيارات العلاج الموجه لمرضى السرطان.
يوفر هذا التحليل الجينومي معلومات دقيقة حول مدى استفادة المريض من مثبطات PARP، مما يعزز خطة العلاج الشخصية ويحسن النتائج السريرية، خصوصًا لسرطانات الثدي والمبيض والبنكرياس. تلتزم مختبراتنا بأعلى معايير هيئة الصحة بدبي والقوانين الاتحادية لدولة الإمارات.
English summary: This identifies HRD status to guide PARP inhibitor therapy, improving personalised oncology care in compliance with UAE DHA standards.
What preparation is needed before sample collection?
No special fasting or medication changes are required unless directed by your physician.
You must provide a valid doctor’s prescription (except for surgery or pregnancy cases). Our team will coordinate the collection of tumor tissue (from the pathology laboratory or a fresh biopsy) and a single peripheral blood draw. The entire home collection process is performed by DHA‑licensed phlebotomists under strict cold‑chain protocols, ensuring sample stability from your doorstep to our ISO‑certified laboratory.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians